Selective and dual action orally active inhibitors of thrombin and factor Xa. 2007

Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK. Rob.J.Young@gsk.com

The synthetic entry to new classes of dual fXa/thrombin and selective thrombin inhibitors with significant oral bioavailability is described. This was achieved through minor modifications to the sulfonamide group in our potent and selective fXa inhibitor (E)-2-(5-chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-(morpholin-4-yl)-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide and these observed activity changes have been rationalised using structural studies.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
June 2007, Bioorganic & medicinal chemistry letters,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
December 2011, Bioorganic & medicinal chemistry letters,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
November 2004, Hamostaseologie,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
May 2003, Seminars in vascular medicine,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
June 2004, Bioorganic & medicinal chemistry letters,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
March 2008, Bioorganic & medicinal chemistry,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
October 2010, Bioorganic & medicinal chemistry letters,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
May 2001, Medizinische Monatsschrift fur Pharmazeuten,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
April 2006, Bioorganic & medicinal chemistry letters,
Robert J Young, and David Brown, and Cynthia L Burns-Kurtis, and Chuen Chan, and Máire A Convery, and Julia A Hubbard, and Henry A Kelly, and Anthony J Pateman, and Angela Patikis, and Stefan Senger, and Gita P Shah, and John R Toomey, and Nigel S Watson, and Ping Zhou
March 2009, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!